Access Biologicals is a sponsor of the 2019 Treg Summit in Boston on May 21 & 22! The 2-day agenda includes workshops, expert speakers, networking, poster sessions and much more!
“As more evidence emerges to validate the enormous therapeutic potential of regulatory T cells, there remains basic scientific and clinical development challenges to implement and commercialize Treg directed therapies…With an exclusive case-study led agenda, this year’s summit will paint a fuller picture of the current status of clinical trials in transplantation, type 1 diabetes, multiple sclerosis and other autoimmune and inflammatory indications.”
We hope to meet you there! For more information or to register, please visit the Treg Summit website
